July 29, 2015
Recommended Topic Related To:

Magnevist

"The US Food and Drug Administration (FDA) has approved an expanded indication for onabotulinum toxin A (Botox, Actavis) for the treatment of adults with upper limb spasticity, according to a company news release.

The expanded i"...

Magnevist




Overdosage
Contraindications

OVERDOSE

Systemic consequences associated with overdosage of MAGNEVIST Injection have not been reported.

CONTRAINDICATIONS

MAGNEVIST is contraindicated in patients with:

  • Chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²), or
  • Acute kidney injury.

Last reviewed on RxList: 4/11/2012
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.